Ganitumab (Anti-IGF-1R / CD221)

Ganitumab (Anti-IGF-1R / CD221) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2456
Sku # A2456-1mg*5
Pricing 1mg*5, $970.00
Feedback